The U.S. has given Merck a $356 million contract to supply up to 100,000 doses of an investigational drug that helped severe COVID-19 patients recover in clinical trials.
A Boston physician had a severe allergic reaction after receiving a COVID-19 vaccine from Moderna.
Novavax has started a phase 3 clinical trial for its COVID-19 vaccine candidate in the U.S.
Pfizer-BioNTech and Moderna’s COVID-19 vaccines will likely hold up against the fast-spreading variant first detected in the U.K.
More articles on healthcare:
What ASC execs need to know about the COVID-19 relief bill: 6 details
USPI headed in 2021: 8 things to know
California surgery center remains open, despite system’s elective surgery postponement
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
